In search of partners: Linking extracellular proteases to substrates

Nature Reviews Molecular Cell Biology

Volumn 8, Issue 3, 2007, Pages 245-257

  Overall, Christopher M ^a   Blobel, Carl P ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; DNA; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL CULTURE; CYTOLOGY; DNA FINGERPRINTING; ENZYME DEGRADATION; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEOMICS; REVIEW;

ANIMALS; HUMANS; PEPTIDE HYDROLASES; PROTEOMICS; SUBSTRATE SPECIFICITY;

EID: 33847276695     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2120     Document Type: Review

References (122)

1. Macfarlane, R. G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202, 498-499 (1964).
2. Davie, E. W. & Ratnoff, O. D. Waterfall sequence for intrinsic blood clotting. Science 145, 1310-1312 (1964).
3. Davie, E. W. & Neurath, H. Identification of a peptide released during autocatalytic activation of trypsinogen. J. Biol. Chem. 212, 515-529 (1955).
4. Black, R. et al. A metalloprotease disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729-733 (1997).
5. Moss, M. L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385, 733-736 (1997).
6. Peschon, J. J. et al. An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284 (1998). An excellent example of linking an enzyme, ADAM17, to several substrates, including TGFα, through the analysis of Adam17-knockout mice and cell-based assays in cells lacking ADAM17, derived from these mice.
7. McQuibban, G. A. et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206 (2000).
8. Parks, W. C., Wilson, C. L. & López-Boado. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Rev. Immunol. 4, 617-629 (2004).
9. Hintermann, E. & Quaranta, V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol. 23, 75-85 (2004).
10. O'Reilly, M. S., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692 (1996).
11. Bergers, G., Javaherian, K., Lo, K. M., Folkman, J. & Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812 (1999).
12. Overall, C. M. Dilating the degradome: matrix metalloproteinase-2 cuts to the heart of the matter. Biochem. J. 383, e5-e7 (2004).
13. Overall, C. M. & Kleifeld, O. Validating MMPs as drug targets and anti-targets for cancer therapy. Nature Rev. Cancer 6, 227-239 (2006).
14. Turk, B. Targeting proteases: successes, failures and future prospects. Nature Rev. Drug Discov. 5, 785-799 (2006).
15. López-Otin, C. & Overall, C. M. Protease degradomics: a new challenge for proteomics. Nature Rev. Mol. Cell Biol. 3, 509-519 (2002).
16. Rosendahl, M. S. et al. Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. J. Biol. Chem. 272, 24588-24593 (1997).
17. Zheng, Y., Saftig, P., Hartmann, D. & Blobel, C. Evaluation of the contribution of different ADAMs to TNF? shedding and of the function of the TNFα ectodomain in ensuring selective stimulated shedding by the TNFα convertase (TACE/ADAM17). J. Biol. Chem. 279, 42898-42906 (2004).
18. Haro, H. et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J. Clin. Invest. 105, 143-150 (2000).
19. Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S. & Overall, C. M. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl Acad. Sci. USA 101, 6917-6922 (2004). A key paper describing the use of isotope mass tags and liquid-chromatography-based massspectrometric identification of cleaved products of native substrates in the cellular context.
20. Zhang, K. et al. Metalloproteinase cleavage of the chemokine SDF-1α induces neuronal apoptosis in HIV encephalitis. Nature Neurosci. 6, 1064-1071 (2003).
21. Shilling, O. & Overall, C. M. Proteomic discovery of protease substrates. Curr. Opin. Chem. Biol. 11, 1-10 (2007).
22. Roghani, M. et al. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 274, 3531-3540 (1999).
23. Loechel, F., Gilpin, B. J., Engvall, E., Albrechtsen, R. & Wewer, U. M. Human ADAM 12 (meltrin α) is an active metalloprotease. J. Biol. Chem. 273, 16993-16997 (1998).
24. Zou, J. et al. Catalytic activity of human ADAM33. J. Biol. Chem. 279, 9818-9830 (2004).
25. Smith, M. M., Shi, L. & Navre, M. Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries. J. Biol. Chem. 270, 6440-6449 (1995).
26. Matthews, D. J. & Wells, J. A. Substrate phage: selection of protease substrates by monovalent phage display. Science 260, 1113-1117 (1993). A classic paper on the development of phage display to screen for protease-cleavage sites.
27. Rosse, G. et al. Rapid identification of substrates for novel proteases using a combinatorial peptide library. J. Comb. Chem. 2, 461-466 (2000).
28. Turk, B. E. & Cantley, L. C. Using peptide libraries to identify optimal cleavage motifs for proteolytic enzymes. Methods 32, 398-405 (2004).
29. Cunningham, B. C., Henner, D. J. & Wells, J. A. Engineering human prolactin to bind to the human growth hormone receptor. Science 247, 1461-1465 (1990).
30. Zhu, L. et al. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). J. Biol. Chem. 278, 22418-22423 (2003).
31. Thornberry, N. A. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911 (1997). Describes the development of a now widely used technique for characterizing the active sites of proteases and for defining cleavage-site specificities.
32. Salisbury, C. M., Maly, D. J. & Ellman, J. A. Peptide microarrays for the determination of protease substrate specificity. J. Am. Chem. Soc. 124, 14868-14870 (2002).
33. Gao, X. et al. High density peptide microarrays. In situ synthesis and applications. Mol. Divers. 8, 177-187 (2004).
34. Marnett, A. B., Nomura, A. M., Shimba, N., Ortiz de Montellano, P. R. & Craik, C. S. Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor. Proc. Natl Acad. Sci. USA 101, 6870-6875 (2004).
35. Greenbaum, D. C. et al. Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem. Biol. 9, 1085-1094 (2002). A comprehensive analysis of the development and use of activity-based probes that launched recent in vivo imaging studies, inhibitor design and active-site characterization.
36. Barrios, A. M. & Craik, C. S. Scanning the prime-site substrate specificity of proteolytic enzymes: a novel assay based on ligand-enhanced lanthanide ion fluorescence. Bioorg. Med. Chem. Lett. 12, 3619-3623 (2002).
37. Turk, B. E., Huang, L. L., Piro, E. T. & Cantley, L. C. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nature Biotechnol. 19, 661-667 (2001).
38. Becherer, J. D. & Blobel, C. P. Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs). Curr. Top. Dev. Biol. 54, 101-123 (2003).
39. Gomis-Ruth, F. X. Structural aspects of the metzincin clan of metalloendopeptidases. Mol. Biotechnol. 24, 157-202 (2003).
40. Overall, C. M. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 22, 51-86 (2002).
41. Tortorella, M. et al. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J. Biol. Chem. 275, 25791-25797 (2000).
42. Fields, G. B. A model for interstitial collagen catabolism by mammalian collagenases. J. Theor. Biol. 153, 585-602 (1991).
43. Boyd, S. E., Pike, R. N., Rudy, G. B., Whisstock, J. C. & Garcia de la Banda, M. PoPS: a computational tool for modeling and predicting protease specificity. J. Bioinform. Comput. Biol. 3, 551-585 (2005).
44. Berman, J. et al. Rapid optimization of enzyme substrates using defined substrate mixtures. J. Biol. Chem. 267, 1434-1437 (1992).
45. Overall, C. M., McQuibban, G. A. & Clark-Lewis, I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol. Chem. 383, 1059-1066 (2002).
46. Boldt, H. B. et al. The Lin12-notch repeats of pregnancy-associated plasma protein-A bind calcium and determine its proteolytic specificity. J. Biol. Chem. 279, 38525-38531 (2004).
47. Torres-Collado, A. X., Kisiel, W., Iruela-Arispe, M. L. & Rodriguez-Manzaneque, J. C. ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2. J. Biol. Chem. 281, 17827-17837 (2006).
48. Overall, C. M. et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol. Chem. 385, 493-504 (2004).
49. Wild-Bode, C., Fellerer, K., Kugler, J., Haass, C. & Capell, A. A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration. J. Biol. Chem. 281, 23824-23829 (2006).
50. Loechel, F., Overgaard, M. T., Oxvig, C., Albrechtsen, R. & Wewer, U. M. Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch. J. Biol. Chem. 274, 13427-13433 (1999).
51. Pei, D. & Weiss, S. J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247 (1995).
52. Tchougounova, E. et al. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280, 9291-9296 (2005).
53. Lundequist, A., Tchougounova, E., Abrink, M. & Pejler, G. Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J. Biol. Chem. 279, 32339-32344 (2004).
54. Sahin, U. et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR-ligands. J. Cell Biol. 164, 769-779 (2004). Mouse embryonic fibroblasts from different Adam- knockout mice were used in cell-based assays to identify which ADAM is required for processing of individual epidermal-growth-factor-receptor ligands.
55. Horiuchi, K. et al. Substrate selectivity and regulation of EGF-receptor ligand sheddases by phorbol esters and calcium influx. Mol. Biol. Cell 18, 176-188 (2007).
56. Hartmann, D. et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts. Hum. Mol. Genet. 11, 2615-2624 (2002).
57. Hinkle, C. L. et al. Selective roles for tumor necrosis factor α-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 279, 24179-24188 (2004).
58. Billinghurst, R. C. et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99, 1534-1545 (1997).
59. Gschwind, A., Hart, S., Fischer, O. M. & Ullrich, A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 22, 2411-2421 (2003).
60. Butler, G. S. & Overall, C. M. Proteomic validation of protease drug targets: Pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometry. Curr. Pharm. Des.13, 263-270 (2007).
61. 2+ influx and PKC activation. J. Cell Biol. 165, 893-902 (2004).
62. Prenzel, N. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888 (1999).
63. Fan, H. & Derynck, R. Ectodomain shedding of TGF-α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18, 6962-6972 (1999).
64. Hwang, I. K., Park, S. M., Kim, S. Y. & Lee, S. T. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim. Biophys. Acta 1702, 79-87 (2004).
65. Lee, A. Y. et al. Identification of caspase-3 degradome by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 4, 3429-3436 (2004).
66. Zhou, X. W., Blackman, M. J., Howell, S. A. & Carruthers, V. B. Proteomic analysis of cleavage events reveals a dynamic two-step mechanism for proteolysis of a key parasite adhesive complex. Mol. Cell. Proteomics 3, 565-576 (2004).
67. Bredemeyer, A. J. et al. A proteomic approach for the discovery of protease substrates. Proc. Natl Acad. Sci. USA 101, 11785-11790 (2004). Describes the successful application of DIGE to identify substrates for granzyme A and B.
68. Bech-Serra, J. J. et al. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol. Cell. Biol. 26, 5086-5095 (2006). DIGE is used to identify substrates for ADAM10 and ADAM17, and the role of these ADAMs in cleaving the newly identified substrates (desmoglein-2 and activated leukocyte cell-adhesion molecule (ALCAM)) was corroborated with cells from ADAM10- or ADAM17-deficient mice.
69. Washburn, M. P., Wolters, D. & Yates, J. R. 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nature Biotechnol. 19, 242-247 (2001).
70. Ahram, M., Adkins, J. N., Auberry, D. L., Wunschel, D. S. & Springer, D. L. A proteomic approach to characterize protein shedding. Proteomics 5, 123-131 (2005).
71. Guo, L. et al. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases. Mol. Cell. Proteomics 1, 30-36 (2002).
72. Dean, R. A. & Overall, C. M. Proteomic discovery of metalloproteinase substrates in the cellular context by iTRAQ™ labeling reveals a diverse MMP-2 substrate degradome. Mol. Cell. Proteomics (in the press).
73. Xia, W. & Wolfe, M. S. Intramembrane proteolysis by presenilin and presenilin-like proteases. J. Cell Sci. 116, 2839-2844 (2003).
74. Ji, C., Guo, N. & Li, L. Differential dimethyl labeling of N-termini of peptides after guanidination for proteome analysis. J. Proteome Res. 4, 2099-2108 (2005). Clever use of chemical guanidination of Lys side chains to mask these from the free N terminus of proteins, potentially including cleaved substrates, which can be adopted for degradomics analysis of substrate cleavage.
75. Van Damme, P. et al. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nature Methods 2, 771-777 (2005). The first comprehensive and working method for N-terminone analysis of proteolysis.
76. McDonald, L., Robertson, D. H., Hurst, J. L. & Beynon, R. J. Positional proteomics: selective recovery and analysis of N-terminal proteolytic peptides. Nature Methods 2, 955-957 (2005).
77. Schulz-Knappe, P. et al. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb. Chem. High Throughput Screen. 4, 207-217 (2001).
78. Adermann, K., John, H., Standker, L. & Forssmann, W. G. Exploiting natural peptide diversity: novel research tools and drug leads. Curr. Opin. Biotechnol. 15, 599-606 (2004).
79. Villanueva, J. et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 76, 1560-1570 (2004).
80. Pan, H. et al. The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study. J. Neurochem. 98, 1763-1777 (2006). Peptidomic analysis of protease-knockout and wildtype mice focusing on neuropeptide products that result from prohormone convertase-2 activity.
81. Egeblad, M., & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2, 161-174 (2002).
82. Gocheva, V. et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556 (2006).
83. Joyce, J. A. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443-453 (2004).
84. Lynch, C. C. et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7, 485-496 (2005). Microarray analysis of a rodent prostate cancer model, which metastasizes to bone, showed upregulation of MMP7 in osteoclasts at the tumour-bone interface, and demonstrated a requirement for MMP7 in receptor activator of NF-κB ligand (RANKL).
85. Willem, M. et al. Control of peripheral nerve myelination by the β-secretase BACE1. Science 314, 664-666 (2006). Expression analysis revealed high amounts of BACE in peripheral nerves during myelination, and BACE-deficient mice were found to display hypomyelination and defects in processing of neuregulin, an ErbB-ligand that is crucial for myelination.
86. Acuff, H. B. et al. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Res. 66, 7968-7975 (2006).
87. Peduto, L. et al. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 25, 5462-5466 (2006).
88. Horiuchi, K. et al. Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 23, 5614-5624 (2003).
89. Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M. & Cravatt, B. F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl Acad. Sci. USA 101, 10000-10005 (2004).
90. Stanton, H. et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648-652 (2005).
91. Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644-648 (2005). In references 90 and 91, Adamts4- and Adamts5-knockout mice were used to test which of these is the relevant aggrecanase in vitro and in a mouse model for osteo arthritis. ADAMTS5 emerged as the principal enzyme.
92. Yamazaki, S. et al. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol. 163, 469-475 (2003).
93. Ruuls, S. R. et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15, 533-543 (2001).
94. Ge, G. & Greenspan, D. BMP1 controls TGF?1 activation via cleavage of latent TGF?-binding protein. J. Cell Biol. 175, 111-120 (2006).
95. Alfalah, M. et al. A point mutation in the juxtamembrane stalk of human angiotensin I-converting enzyme invokes the action of a distinct secretase. J. Biol. Chem. 276, 21105-21109 (2001).
96. Jackson, L. F. et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22, 2704-2716 (2003).
97. Sternlicht, M. D. et al. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132, 3923-3933 (2005).
98. de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411-423 (2005).
99. Lammich, S. et al. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96, 3922-3927 (1999).
100. Schlöndorff, J. S., Lum, L. & Blobel, C. P. Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the TNF? convertase (TACE). J. Biol. Chem. 276, 14665-14674 (2001).
101. Hikita, A. et al. Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand. J. Biol. Chem. 281, 36846-36855 (2006).
102. Sternlicht, M. D. et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137-146 (1999).
103. Wen, C., Metzstein, M. M. & Greenwald, I. SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signaling. Development 124, 4759-4767 (1997).
104. Pan, D. & Rubin, J. KUZBANIAN controls proteolytic processing of NOTCH and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271-280 (1997).
105. Li, Q., Park, P. W., Wilson, C. L. & Parks, W. C. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646 (2002). An elegant analysis of the role of matrilysin (also known as MMP7) in shedding syndecan-1 with an attached CXC chemokine, and the requirement of this process in neutrophil efflux to sites of lung injury in mice.
106. Vassar, R. et al. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
107. Roberds, S. L. et al. BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317-1324 (2001).
108. Buxbaum, J. D. et al. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767 (1998).
109. Weskamp, G. et al. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nature Immunology 7, 1393-1398 (2006). Gain- and loss-of-function studies with mouse cells, in vivo shedding studies in mice and use of a selective pharmacological inhibitor on mouse and human B cells identified ADAM10 as the major sheddase for CD23, a target for the treatment of allergic disease and rheumatoid arthritis.
110. Puente, X. S., Sanchez, L. M., Overall, C. M. & Lopez-Otin, C. Human and mouse proteases: a comparative genomic approach. Nature Rev. Genet. 4, 544-558 (2003). An excellent review on the identification and classification of all proteases in the human genome as well as diseases of proteolysis.
111. McDermott, M. F. et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133-144 (1999).
112. Selkoe, D. J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453 (1998).
113. Milla, M. E. et al. Specific sequence elements are required for the expression of functional tumor necrosis factor-α-converting enzyme (TACE). J. Biol. Chem. 274, 30563-30570 (1999).
114. Grams, F. et al. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur. J. Biochem. 228, 830-841 (1995).
115. Zhao, Y. G., Wei, P. & Sang, Q. X. Inhibitory antibodies against endopeptidase activity of human adamalysin 19. Biochem. Biophys. Res. Commun. 289, 288-294 (2001).
116. Mort, J. S. & Roughley, P. J. Production of antibodies against degradative neoepitopes in aggrecan. Methods Mol. Med. 100, 237-250 (2004).
117. Parkin, E. T. et al. Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-α. Biochemistry 41, 4972-4981 (2002).
118. Murphy, G. et al. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem. Soc. Symp., 65-80 (2003).
119. Gonzales, P. E. et al. Inhibition of the TNFα converting enzyme (TACE) by its Pro domain. J. Biol. Chem. 279, 31638-31645 (2004).
120. McQuibban, G. A. et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160-1167 (2002).
121. Blank, M. & Blind, M. Aptamers as tools for target validation. Curr. Opin. Chem. Biol. 9, 336-342 (2005).
122. Akashi, H., Matsumoto, S. & Taira, K. Gene discovery by ribozyme and siRNA libraries. Nature Rev. Mol. Cell Biol. 6, 413-422 (2005).